Home › Lupus › Texas › Arlington
Lupus clinical trials in Arlington, TX
4 studies for Lupus are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RecruitingPhase 3
- Research Site, Colleyville · 10 mi away
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RecruitingPhase 2
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
- Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville · 10 mi away
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50718, Mansfield · 12 mi away
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
RecruitingPhase 2
- Investigative Site, Arlington
- Investigative Site, Colleyville · 10 mi away
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Durham, NC12 studies
- Houston, TX12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Boston, MA8 studies
- Santa Monica, CA8 studies
- Chicago, IL8 studies
- Los Angeles, CA8 studies
- Clearwater, FL8 studies
Other studies in Arlington
- Crohn's Disease5 studies
- Psoriatic Arthritis4 studies
- Sjogren's Syndrome4 studies
- Chronic Kidney Disease4 studies
- Ulcerative Colitis4 studies
- Atopic Dermatitis (Eczema)4 studies
- Rheumatoid Arthritis4 studies
- Non-Small Cell Lung Cancer4 studies
- Steatotic Liver Disease4 studies
- Overactive Bladder3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- High Blood Pressure3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.